Skip to main content
. 1999 Nov;58(Suppl 1):I56–I60. doi: 10.1136/ard.58.2008.i56

Figure 1  .

Figure 1  

CRP and ESR measurements in a randomised placebo controlled trial of infliximab in RA. Patients were treated on day 0 with a single, two hour infusion of either placebo (circle), 1 mg/kg infliximab (diamond) or 10 mg/kg infliximab (triangle). Values are means of 24 patients at each point (25 for 1 mg/kg group). * p < 0.05; † p < 0.01; ‡ p < 0.001. Reproduced with modification from Lancet 1994;344:1105-10 by kind permission of the editor.